Shirleyann Metcalfe, 64, told i she was almost instantly approved for online pharmacist Voy’s GLP1 weight-loss programme – ...

America's kitchen trash bins are receiving more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, ...

One the bigger drivers of Medicaid’s rising costs is the ballooning expense of covering weight loss drugs, a state Senate ...

America's kitchen trash bins are receiving more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, ...

Compounded GLP-1 medications are typically safe for most people. But since compounded GLP-1s aren’t FDA-approved, the FDA ...

Swiss medical technology company Ypsomed's contract with Novo Nordisk includes the supply of injection pens for the Danish drugmaker's next-generation experimental obesity drug CagriSema, a source ...

New research has found that nearly 137 million adults—or more than half of all U.S. adults—are eligible for semaglutide ...

Here are four things to know about knee pain and GLP-1s based on studies and surgeon observations from 2024: ...

According to Reuters and CNN, Novo Nordisk announced Monday that it has launched its popular obesity drug Wegovy in China, ...

Coverage for obesity drugs like Ozempic and Wegovy among large companies (with 500 or more employees) rose to 44% this year, ...

More than half of U.S. adults now qualify to take semaglutide, the popular diabetes and weight loss drug sold under the brand names Ozempic and Wegovy.

A survey by consulting firm Mercer shows that close to half of U.S. companies with more than 500 employees now cover drugs ...